NMN
Natural health product licensed in Canada
- Other names
- Nicotinamide mononucleotide
- Licence holder
- Bioclinic Naturals Inc.
- NPN or DIN-HM
- 80124893
- Status
- Active licence
- Licence date
- 12 June 2023
- Revision date
- 3 February 2026
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Acide stéarique, Cellulose, Silice, NA, Eau, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Source of vitamin B3), a factor in the maintenance of good health. Source of an antioxidant/Provides antioxidant. Source of an antioxidant/Provides an antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. A factor in the maintenance of good health. A factor in normal growth and development. Supports biological functions which play a key role in the maintenance of good health. Helps normal growth and development. Helps in energy metabolism/(and) tissue formation. Helps (to) maintain/support the body's ability to metabolize nutrients. NMN is a NAD+ precursor which is a factor in normal growth and development. NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health. NMN is a NAD+ precursor which is an important cofactor in energy metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80124893
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.